{
    "nct_id": "NCT01020838",
    "title": "An Open-label, Non-randomized Study to Evaluate the Efficacy and Safety of BAY94-9172 (ZK 6013443) Positron Emission Tomography (PET) Imaging for Detection/Exclusion of Cerebral Beta-amyloid When Compared to Postmortem Histopathology",
    "status": "COMPLETED",
    "last_update_time": "2016-04-27",
    "description_brief": "To determine the sensitivity and specificity of the visual assessment of tracer uptake in the Florbetaben PET images compared to histological verification of the presence or absence of cerebral \u03b2-amyloid in the respective histopathologic post mortem specimens as the standard of truth",
    "description_detailed": "N/A",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "DIAGNOSTIC",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "Subjects were screened at 15 study centers in Australia, Germany, France, Japan, and the U.S.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "All Study Participants",
                    "description": "All patients enrolling into the study"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "218"
                                }
                            ]
                        },
                        {
                            "type": "Safety Analysis Set",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Two patients were excluded from this population because injection of florbetaben was not done.",
                                    "numSubjects": "216"
                                }
                            ]
                        },
                        {
                            "type": "Interim Analysis Set (Primary Efficacy)",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)",
                                    "numSubjects": "41"
                                }
                            ]
                        },
                        {
                            "type": "Final Analysis Set (Whole Brain)",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Final analysis set comparing PET scans with different histopathological evaluations.",
                                    "numSubjects": "97"
                                }
                            ]
                        },
                        {
                            "type": "First Annual Repeat Injection",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Patients returning for first follow-up administration and PET-scan.",
                                    "numSubjects": "91"
                                }
                            ]
                        },
                        {
                            "type": "Second Annual Repeat Injection",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Patients returning for second follow-up administration and PET-scan.",
                                    "numSubjects": "34"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "35"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "183"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Death",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "90"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "9"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                }
                            ]
                        },
                        {
                            "type": "Most common: Study ended by sponsor",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "77"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "Participants in the safety analysis set were treated with study drug.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "Safety Analysis Set",
                    "description": "All study participants who received any amount of florbetaben were included in the safety analysis set."
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "216"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "74.4",
                                            "spread": "15.4"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "104"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "112"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "213"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "55"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "159"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "BMI (kg/m^2)",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "kg/m^2",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "23.617",
                                            "spread": "5.213"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Body weight",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "kg",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "64.95",
                                            "spread": "18.44"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Height",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "cm",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "164.70",
                                            "spread": "12.34"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Baseline clinical diagnosis",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Alzheimer's Disease",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "137"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Dementia with Lewy bodies",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Other dementia subject",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Healthy volunteers",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "32"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Healthy negative control",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "11"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Sensitivity and Specificity of the Majority Read of Visual Assessment of Tracer Uptake Compared to Histological Verification of the Presence or Absence of Cerebral Beta-amyloid in Postmortem Specimens",
                    "description": "The sensitivity/specificity of the visual assessment were calculated based on the majority read assessment of regional tracer uptake. This result was derived from assessments by 3 independent readers for brain regions of a subject where a Standard of Truth (SOT) was available. The SOT for this analysis was a centralized histopathological determination of \u03b2-amyloid presence/absence based on both Bielschowsky silver and immunohistochemical staining. Based on the PET images, a brain region was classified as \"normal\" or \"abnormal\" depending on the presence or absence of regional tracer uptake in the respective region. \"Normal\" therefore meant absence of \u03b2-amyloid and \"abnormal\" presence of \u03b2-amyloid. Sensitivity was defined as the percentage of abnormal brain regions from all regions where an SOT was available and the SOT was \"\u03b2-amyloid present\". Specificity was defined as the percentage of normal brain regions from all regions where an SOT was available and was \"\u03b2-amyloid not present\".",
                    "populationDescription": "All participants included in the Interim Analysis Set were included in this analysis.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "percentage of regions",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Sensitivity (Interim Analysis Set)",
                            "description": "The full analysis set consisted of 31 subjects for whom both brain specimen with a valid Standard of Truth (SOT) in at least one brain region and a florbetaben PET scan were available and 10 healthy controls for whom a florbetaben PET scan was available and whose SOT was considered \u03b2-amyloid negative by definition."
                        },
                        {
                            "id": "OG001",
                            "title": "Specificity (Interim Analysis Set)",
                            "description": "The full analysis set consisted of 31 subjects for whom both brain specimen with a valid Standard of Truth (SOT) in at least one brain region and a florbetaben PET scan were available and 10 healthy controls for whom a florbetaben PET scan was available and whose SOT was considered \u03b2-amyloid negative by definition."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "41"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "41"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Total",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "77.36"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "94.20"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Frontal Cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85.71"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "95.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Occipital Cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "88.89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "86.36"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Hippocampus",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "57.14"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "100.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Anterior Cingulate Cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "90.00"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "85.71"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Posterior Cingulate Cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "81.82"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "94.44"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Cerebellar Cortex",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "100.00"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000"
                            ],
                            "groupDescription": "For the primary analysis, point estimates together with normal-approximated, two sided 95% confidence intervals, were given for sensitivity in beta-amyloid detection based on the majority read.\n\nThe following hypothesis was formulated for sensitivity:\n\nH0,sens: sensitivity \u2264 0.6 vs. H1, sens: sensitivity \\> 0.6 H0,sens was to be rejected if the lower bound of the two-sided 95% CI is larger than 0.6",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "paramType": "Sensitivity",
                            "paramValue": "0.774",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.654",
                            "ciUpperLimit": "0.894",
                            "estimateComment": "Point estimate of sensitivity was calculated by the method of Rao and Scott. Variance for sensitivity is based on subjects that contribute at least one brain region, which is amyloid positive according to the SoT"
                        },
                        {
                            "groupIds": [
                                "OG001"
                            ],
                            "groupDescription": "For the primary analysis, point estimates together with normal-approximated, two sided 95% confidence intervals, were given for specificity in amyloid detection based on the majority read.\n\nThe following hypothesis was formulated for specificity:\n\nH0,spec: specificity \u2264 0.8 vs. H1, spec: specificity \\> 0.8 H0,spec was to be rejected if the lower bound of the two-sided 95% CI is larger than 0.8",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "paramType": "Specificity",
                            "paramValue": "0.942",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.886",
                            "ciUpperLimit": "0.998",
                            "estimateComment": "Point estimate of specificity was calculated using the method of Rao and Scott. Variance for specificity is based on subjects that contribute at least one brain region, which is amyloid negative according to the SoT"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral Neuritic \u03b2-amyloid Plaques Compared With the Histopathological Verification With Bielschowsky Silver Staining (SOT 1).",
                    "description": "Sensitivity and specificity of the whole brain visual assessment were calculated. Any brain with a region classified as abnormal from PET imaging was to be classified as abnormal for the \"whole brain\" assessment. This result was derived from assessments by 3 independent readers for a subject where a Standard of Truth (SOT) was available. The SOT for this analysis was based on a centralized histopathological assessment of the presence/absence of \u03b2-amyloid based on Bielschowsky silver staining (SOT 1).\n\nThe sensitivity was defined as the proportion of brains classified as abnormal from all brains where this SOT was available and was \"\u03b2-amyloid present\". The specificity was defined as the proportion of brains classified as normal from all brains where this SOT was available and was \"\u03b2-amyloid not present\".",
                    "populationDescription": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral \u03b2-amyloid Plaques Compared with the Histopathological Verification with Bielschowsky silver staining (SOT 1).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "percentage of subjects",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Full Analysis Set Final Clinical Study Report",
                            "description": "The full analysis of the final clinical study report consisted of data from 97 subjects, including 87 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT)."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "97"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Sensitivity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "96.49",
                                            "lowerLimit": "91.71",
                                            "upperLimit": "100.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Specificity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85.00",
                                            "lowerLimit": "73.93",
                                            "upperLimit": "96.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral Neuritic \u03b2-amyloid Plaques Compared With Histopathological Verification With Bielschowsky Silver Staining and Immunohistochemistry (SOT 2).",
                    "description": "Sensitivity and specificity of the whole brain visual assessment were calculated. Any brain with a region classified as abnormal from PET imaging was to be classified as abnormal for the \"whole brain\" assessment. This result was derived from assessments by 3 independent readers for a subject where a Standard of Truth (SOT) was available. The SOT for this analysis was based on a centralized histopathological assessment of the presence/absence of \u03b2-amyloid based on Bielschowsky silver staining and immunohistochemistry (SOT 2).\n\nThe sensitivity was defined as the proportion of brains classified as abnormal from all brains where this SOT was available and was \"\u03b2-amyloid present\". The specificity was defined as the proportion of brains classified as normal from all brains where this SOT was available and was \"\u03b2-amyloid not present\".",
                    "populationDescription": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral neuritic \u03b2-amyloid Plaques Compared with the Histopathological Verification with Bielschowsky silver staining and immunohistochemistry (SOT 2).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "percentage of subjects",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Full Analysis Set Final Clinical Study Report",
                            "description": "The full analysis of the final clinical study report consisted of data from 97 subjects, including 87 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT)."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "97"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Sensitivity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "96.72",
                                            "lowerLimit": "92.25",
                                            "upperLimit": "100.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Specificity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "94.44",
                                            "lowerLimit": "86.96",
                                            "upperLimit": "100.00"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral Neuritic \u03b2-amyloid Plaques Compared With the Histopathological Verification According to CERAD Criteria (SOT 3).",
                    "description": "Sensitivity and specificity of the whole brain visual assessment were calculated. Any brain with a region classified as abnormal from PET imaging was to be classified as abnormal for the \"whole brain\" assessment. This result was derived from assessments by 3 independent readers for a subject where a Standard of Truth (SOT) was available. The SOT for this analysis was based on a histopathological assessment of the presence/absence of \u03b2-amyloid according to CERAD Criteria (SOT 3).\n\nThe sensitivity was defined as the proportion of brains classified as abnormal from all brains where this SOT was available and was \"\u03b2-amyloid present\". The specificity was defined as the proportion of brains classified as normal from all brains where this SOT was available and was \"\u03b2-amyloid not present\".",
                    "populationDescription": "Sensitivity and Specificity of the Majority Read \"Whole Brain\" Visual Assessment in Detecting/Excluding Cerebral \u03b2-amyloid Plaques Compared with the Histopathological Verification according to CERAD Criteria (SOT 3).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "dispersionType": "95% Confidence Interval",
                    "unitOfMeasure": "percentage of subjects",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Full Analysis Set Final Clinical Study Report",
                            "description": "The full analysis of the final clinical study report consisted of data from 97 subjects, including 87 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT)."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "97"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Sensitivity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "96.49",
                                            "lowerLimit": "91.71",
                                            "upperLimit": "100.00"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Specificity",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "85.00",
                                            "lowerLimit": "73.93",
                                            "upperLimit": "96.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Sensitivity and Specificity of the Subject Level Composite SUVR Calculated Based on Pathology Results.",
                    "description": "Sensitivity and specificity of subject level composite Standard Uptake Value Ratios (SUVR) by SOT for subjects with available brain tissue and 10 healthy volunteers. The SUVR were determined as a quantitative measure of tracer uptake. The SUV is defined as the ratio of the tissue radioactivity concentration c (in MBq/kg) at time point t, and the injected activity (in MBq), extrapolated to the same time (t) divided by the body weight (in kg). SUV numbers were then used to derive SUV ratios (SUVR) using the SUV from the cerebellar cortex as reference. SOTs comprised Bielschowsky silver staining (SOT 1), Bielschowsky silver staining with immunohistochemistry (SOT 2) and neuropathology assessment according to CERAD (SOT 3). SUVR analysis was performed for baseline and available follow-up scans. The optimal threshold for the distinction between \u03b2-amyloid present yes/no according to the respective SOT was derived based on ROC curve analyses and used to calculate sensitivity and specificity.",
                    "populationDescription": "Sensitivity and Specificity of the subject level Composite SUVR with three different SOTs.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "percentage of subjects",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Sensitivity of Subject Level Composite SUVR by SOT",
                            "description": "The analysis set consisted of data from 96 subjects, including 86 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT). Sensitivity of subject level composite SUVR by SOT for baseline scans and last available scans are reported."
                        },
                        {
                            "id": "OG001",
                            "title": "Specificity of Subject Level Composite SUVR by SOT",
                            "description": "The analysis set consisted of data from 96 subjects, including 86 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT). Specificity of subject level composite SUVR by SOT for baseline scans and last available scans are reported."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "96"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "96"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "SOT 1 (initial period)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "82"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 2 (initial period)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "90"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "91"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 3 (initial period)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "90"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 1 (last available scan)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "88"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "85"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 2 (last available scan)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "89"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "94"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 3 (last available scan)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "95"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "87"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Subject Level Composite SUVRs by SOT for Baseline and Available Follow-Up Scans",
                    "description": "Subject level composite SUVRs (calculated as mean of SUVRs from the frontal, parietal, lateral temporal, anterior and posterior cingulate, and occipital cortices) by SOT are reported for subjects with available brain tissue. The initial drug administration group includes additionally 10 healthy controls who were considered as \u00df-amyloid negative. The SOTs for deceased subjects were based on Bielschowsky silver staining (SOT 1), Bielschowsky silver staining in combination with immunohistochemistry (SOT 2) and neuropathology assessment according to CERAD (SOT 3). SUVR analysis was performed for baseline and available follow-up scans.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "Standardized Uptake Value Ratio (SUVR)",
                    "timeFrame": "90-110 minutes post injection (PET image acquisition)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Initial Drug Administration",
                            "description": "The analysis set consisted of data from 96 subjects, including 86 subjects with brain specimens and 10 young healthy controls considered to be \u03b2-amyloid-negative as a valid Standard of Truth (SOT). Descriptive statistics of subject level Composite SUVR by SOT for baseline scans and last available scans are reported."
                        },
                        {
                            "id": "OG001",
                            "title": "1st Repeat Drug Administration",
                            "description": "The analysis set consisted of data from 20 subjects with brain specimens available."
                        },
                        {
                            "id": "OG002",
                            "title": "2nd Repeat Drug Administration",
                            "description": "The analysis set consisted of data from 3 subjects with brain specimens available."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "96"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "3"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "SOT 1 (abeta absent)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.296",
                                            "spread": "0.232"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.319",
                                            "spread": "0.414"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.537",
                                            "spread": "NA",
                                            "comment": "Sample size too low"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 1 (abeta present)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.707",
                                            "spread": "0.276"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.625",
                                            "spread": "0.250"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.699",
                                            "spread": "0.046"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 2 (abeta absent)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.237",
                                            "spread": "0.140"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.175",
                                            "spread": "0.364"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.537",
                                            "spread": "NA",
                                            "comment": "Sample size too low"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 2 (abeta present)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.714",
                                            "spread": "0.273"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.632",
                                            "spread": "0.244"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.699",
                                            "spread": "0.046"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 3 (abeta absent)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.263",
                                            "spread": "0.170"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.260",
                                            "spread": "0.390"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "NA",
                                            "spread": "NA",
                                            "comment": "Sample size too low"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SOT 3 (abeta present)",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.729",
                                            "spread": "0.270"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.639",
                                            "spread": "0.236"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.645",
                                            "spread": "0.099"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "1",
            "timeFrame": "All treatment emergent adverse events were recorded within 7 days of the application or follow-up application of study drug.",
            "description": "As this study was conducted in an end-of-life population, death occurring outside 7 day follow-up period after administration of the drug was not collected as part of the study SAE data unless investigator considered the event to be related to drug administration or study procedure.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Initial Drug Administration",
                    "description": "Subjects with TEAEs within 7 days of the initial administration of florbetaben.",
                    "seriousNumAffected": 12,
                    "seriousNumAtRisk": 216,
                    "otherNumAffected": 48,
                    "otherNumAtRisk": 216
                },
                {
                    "id": "EG001",
                    "title": "1st Repeat Drug Administration",
                    "description": "Subjects with TEAEs within 7 days of the 1st repeat drug administration.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 91,
                    "otherNumAffected": 22,
                    "otherNumAtRisk": 91
                },
                {
                    "id": "EG002",
                    "title": "2nd Repeat Drug Administration",
                    "description": "Subjects with TEAEs within 7 days of the 2nd repeat drug administration.",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 34,
                    "otherNumAffected": 14,
                    "otherNumAtRisk": 34
                }
            ],
            "seriousEvents": [
                {
                    "term": "Frontotemporal dementia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Dementia, Alzheimers' type",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Colitis",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Spinal compression fracture",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Pneumonia aspiration",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Pubis fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Arthralgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Colon cancer",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Hepatic cancer metastatic",
                    "organSystem": "Hepatobiliary disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Heat stroke",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Convulsion",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Respiratory failure",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Oedema peripheral",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Delirium",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Cardiac Failure",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Injection site erythema",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Injection site pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Puncture site reaction",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 7,
                            "numAffected": 7,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Pyrexia",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 8,
                            "numAffected": 7,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Blood pressure increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Hypertension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Injection site hematoma",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 10,
                            "numAffected": 10,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Haemorrhage subcutaneous",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Haematoma",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 6,
                            "numAffected": 6,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Erythema",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 5,
                            "numAffected": 4,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Injection site hemorrhage",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Asthma",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Emphysema",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Rash",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 2,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Injection site bruising",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Frequent bowel movements",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Vessel puncture site swelling",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Procedural pain",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Papule",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Cystitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                },
                {
                    "term": "Procedural hypertension",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 16.1",
                    "assessmentType": "NON_SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 216
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 91
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 34
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "LTE60",
                "restrictiveAgreement": true
            },
            "pointOfContact": {
                "title": "Dr. Juergen Hirschfeld",
                "organization": "Piramal Imaging",
                "email": "juergen.hirschfeld@piramal.com",
                "phone": "49 30 461 1246 15"
            }
        }
    },
    "target_category": "N/A",
    "drug": [
        "Florbetaben (BAY94-9172; ZK 6013443)"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The study evaluates BAY94-9172 (florbetaben), an 18F-labeled PET tracer that binds cerebral \u03b2-amyloid and is used to detect/exclude amyloid plaques in vivo \u2014 the trial's primary aim is diagnostic accuracy (sensitivity/specificity) versus postmortem histopathology, not therapeutic effect or symptom change. \ue200cite\ue202turn0search6\ue202turn0search0\ue202turn0search5\ue201",
        "Act: Extracted details from the trial description \u2014 drug/intervention = BAY94-9172 (ZK 6013443; florbetaben); intervention type = PET imaging tracer; primary outcome = sensitivity and specificity of visual/quantitative tracer uptake assessment compared to histology. These sources describe the same tracer and diagnostic purpose. \ue200cite\ue202turn0search0\ue202turn0search3\ue202turn0search2\ue201",
        "Reflect: Classification decision \u2014 this is a diagnostic imaging study (non-therapeutic). It does not meet any of the four therapeutic categories (disease-targeted biologic, disease-targeted small molecule, cognitive enhancer, or neuropsychiatric symptom improvement), so the correct category is 'N/A'. Supporting publications and registry entries confirm florbetaben is a PET tracer for amyloid detection rather than a treatment. \ue200cite\ue202turn0search6\ue202turn0search5\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}